You have 9 free searches left this month | for more free features.

rituximab

Showing 2651 - 2665 of 2,665

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non-Hodgkin's Lymphoma Trial in Magdeburg (Rituximab, DHAP, TEC)

Unknown status
  • Non-Hodgkin's Lymphoma
  • Rituximab
  • +3 more
  • Magdeburg, Germany
    University of Magdeburg
Oct 5, 2006

Lymphoma, High-Grade Trial in Magdeburg (Bendamustine, Rituximab)

Unknown status
  • Lymphoma, High-Grade
  • Magdeburg, Germany
    University of Magdeburg, departement of Hematology and Oncology
Oct 5, 2006

Lymphoma, Non-Hodgkin, Lymphoma, Low-Grade Trial in United States (ibritumomab tiuxetan (Zevalin®))

Completed
  • Lymphoma, Non-Hodgkin
  • Lymphoma, Low-Grade
  • ibritumomab tiuxetan (Zevalin®)
  • Loma Linda, California
  • +7 more
Oct 18, 2006

Non-Hodgkin's Lymphoma Trial in United States (Zevalin (ibritumomab tiuxetan), Rituxan (rituximab))

Terminated
  • Non-Hodgkin's Lymphoma
  • Zevalin (ibritumomab tiuxetan)
  • Rituxan (rituximab)
  • Huntsville, Alabama
  • +66 more
Sep 8, 2006

Systemic Lupus Erythematosus, ANCA Associated Vasculitis Trial in Cambridge (Rituximab)

Completed
  • Systemic Lupus Erythematosus
  • ANCA Associated Vasculitis
  • Rituximab
  • Cambridge, Cambridgeshire, United Kingdom
    Addenbrooke's Hospital
Feb 16, 2006

Autoimmune Thrombocytopenic Purpura Trial in Créteil (Mabthéra)

Terminated
  • Autoimmune Thrombocytopenic Purpura
  • Créteil, France
    Hôpital Henri Mondor
Oct 25, 2005

Aggressive Non-Hodgkin's Lymphoma in the Elderly. Trial in Worldwide (Cyclophosphamide, oncovin, myocet, prednisone & rituximab

Unknown status
  • Aggressive Non-Hodgkin's Lymphoma in the Elderly.
  • Cyclophosphamide, oncovin, myocet, prednisone & rituximab (R-COMP)
  • Paris, France
  • +4 more
Oct 26, 2005

CD20-Positive Large B-Cell Lymphoma Trial in France (ACVBP, ACE, rituximab)

Terminated
  • CD20-Positive Large B-Cell Lymphoma
  • Créteil, France
  • +4 more
Sep 13, 2005

Lymphoma, Non-Hodgkin Trial in United States (Recombinant Human Interleukin-2 and Rituximab)

Completed
  • Lymphoma, Non-Hodgkin
  • Recombinant Human Interleukin-2 and Rituximab
  • Tucson, Arizona
  • +32 more
Feb 2, 2006

AIDS Related Lymphoma Trial in Clamart (rituximab, CHOP)

Terminated
  • AIDS Related Lymphoma
  • Clamart, France
    Service de Medecine Interne Hopital Antoine Beclere
Aug 16, 2005

Lymphoma, Non-Hodgkin Trial in United States (Recombinant Human Interleukin-2 and Rituximab)

Completed
  • Lymphoma, Non-Hodgkin
  • Recombinant Human Interleukin-2 and Rituximab
  • Little Rock, Arkansas
  • +64 more
Feb 2, 2006

Low-Grade or Follicular B-Cell Non-Hodgkin's Lymphoma Trial in Canada, United States (rituximab)

Completed
  • Low-Grade or Follicular B-Cell Non-Hodgkin's Lymphoma
  • rituximab
  • Little Rock, Arkansas
  • +30 more
Sep 13, 2005

Peripheral Neuropathy Trial (Rituxan)

Unknown status
  • Peripheral Neuropathy
  • (no location specified)
Jun 23, 2005

Chronic Lymphocytic Leukemia Trial in United States (Nipent, Cytoxan, Rituxan)

Unknown status
  • Chronic Lymphocytic Leukemia
  • Nipent, Cytoxan, Rituxan
  • Muscle Shoals, Alabama
  • +51 more
Aug 17, 2005

Lymphoma, Low-Grade Trial in United States (FavId (Id-KLH) active immunotherapy)

Unknown status
  • Lymphoma, Low-Grade
  • FavId (Id-KLH) active immunotherapy
  • La Jolla, California
  • +11 more
Jun 23, 2005